TSHAbenzinga

Taysha Gene Therapies Receives Orphan Drug Designation From European Commission For TSHA-120 For Treatment Of Giant Axon Neuropathy (GAN)

Summary

No summary available.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on May 3, 2022 by benzinga

    Taysha Gene Therapies Receives Orphan Drug Designation From European Commission For TSHA-120 For Treatment Of Giant Axon Neuropathy (GAN) | TSHA Stock News | Candlesense